Forodesine Hydrochloride from Canada
Forodesine HCl is a purine nucleoside phosphorylase inhibitor with transition state analog structure for T-cell malignancies. The aromatic heterocyclic hydrochloride salt qualifies as a drug under HTS 2934.99.30.00.
Duty Rate — Canada → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Specify hydrochloride salt form stability and counterion exchange prevention
• Provide orphan drug and fast track designation documentation
• Document high potency API handling requirements (glove box filling)